A study in healthy people to compare how 2 different formulations of survodutide are taken up by the body
This early-stage clinical trial looks at two different versions, or formulations, of a new medicine called survodutide. Survodutide is being developed to help treat conditions linked to metabolism, such as weight management and liver health. Before a new medicine can be used widely, researchers need to know how it behaves in the human body. By testing two slightly different ways of making the medicine, scientists can compare how quickly and effectively each one gets into the bloodstream. The study involves healthy adult volunteers aged 18 and older. Taking part will involve receiving both forms of the medicine, having blood samples taken over time, and regular health checks. This kind of research helps ensure that future medicines are safe, effective, and easy for patients to use.
At a glance
What is this study about?
When scientists invent a new medicine, making the active drug is only the first step. They also need to find the best 'formulation'—the exact mixture of ingredients that delivers the medicine safely into the body. This study compares two different recipes of an experimental medicine called survodutide to see which one works best.
Survodutide is a new treatment being studied for metabolic conditions, such as obesity and related liver problems. It mimics natural gut hormones that help control appetite and blood sugar. In this trial, researchers want to see how quickly the body absorbs survodutide, how long it stays in the blood, and how it is cleared away. This kind of study is called a human pharmacology or Phase 1 study.
Because this is an early test to understand the drug's journey through the body, it is carried out in healthy volunteers rather than people with existing health conditions. By testing in healthy bodies first, scientists can get clean, reliable measurements without other illnesses or medications confusing the results.
The findings from this study will help the research team choose the most effective formulation of survodutide to take forward into larger, long-term studies with patients who need the treatment.
Key takeaways
- Phase 1 trial comparing two different recipes of the medicine survodutide.
- Open to healthy adults aged 18 and over.
- Aims to measure how the body absorbs and clears each formulation.
- Involves health checks, dosing, and regular blood tests at a clinical unit.
- Participation is voluntary, and you can leave at any time.
Who may be eligible?
This study is open to healthy men and women aged 18 and older. To join, you should generally be in good overall health, with no major ongoing medical conditions.
Because this is a study in healthy volunteers, people with serious long-term health problems—such as heart disease, kidney issues, or diabetes—will usually not be able to take part. Researchers also check that your liver and kidney function tests are within normal limits before you can join.
You may not be eligible if you take regular prescription medicines that could interfere with the study, or if you are pregnant, planning to become pregnant, or breastfeeding. The study team will review your full medical history and perform simple health checks to make sure taking part is safe for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or older.
- I consider myself to be in good general health.
- I do not have any serious, long-term medical conditions.
- I am not currently taking regular prescription medicines that could interfere with the study.
- I am not pregnant, planning a pregnancy during the study, or breastfeeding.
- I am willing and able to attend clinic visits and give blood samples.
What does participation involve?
If you take part, you will be invited to a clinical research unit for a thorough health screening, including blood tests, heart traces (ECGs), and a physical check-up. Once accepted, you will receive the two different formulations of survodutide at different times, with a rest period (called a washout period) in between to let each dose fully leave your system. You will need to stay at the clinic or visit regularly so the medical team can take blood samples at set times to measure drug levels. You will also be closely monitored for any side effects. The total duration usually spans several weeks from the first screening visit to the final follow-up check.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What is a healthy volunteer trial?
It is an early-stage study where people without the condition being treated test a medicine to help researchers see how it is absorbed and tolerated in a healthy body.
What is survodutide?
Survodutide is an experimental medicine being developed to help treat obesity, type 2 diabetes, and related metabolic conditions.
Will taking part cost me anything?
No, the study medicine and all tests are free. Healthy volunteer trials usually cover your travel expenses, and participants often receive compensation for their time and effort.
Can I leave the study if I feel uncomfortable?
Yes. Taking part is completely voluntary. You can choose to stop and leave the study at any point without any penalty.
Why compare two different formulations?
Testing different recipes or forms helps scientists figure out which version is absorbed best and causes the fewest side effects.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.